Chemours Announces Commencement of Public Offering Of Senior Notes
Chemours Announces Commencement of Public Offering Of Senior Notes |
[21-May-2018] |
WILMINGTON, Del., May 21, 2018 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, chemical solutions and titanium technologies, today announced the commencement of a registered underwritten public offering of fixed rate senior notes. The net proceeds of the offering are expected to be used (i) to fund the purchase price and accrued and unpaid interest for up to $250 million of Chemours' outstanding 6.625% senior notes due 2023 (the "existing 2023 dollar notes") and any and all of Chemours' outstanding 6.125% senior notes due 2023 (the "existing 2023 euro notes" and, together with the existing 2023 dollar notes, the "existing 2023 notes") validly tendered and accepted for payment pursuant to Chemours' previously announced cash tender offers for up to $250 million of the existing 2023 dollar notes and any and all existing 2023 euro notes (the "Tender Offers"), (ii) to the extent applicable, to fund the redemption price and accrued and unpaid interest for any existing 2023 euro notes that remain outstanding after the completion or termination of the Tender Offers, and (iii) the remaining net proceeds, if any, for general corporate purposes. Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Barclays Capital Inc., Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., RBC Capital Markets, LLC, BofA Merrill Lynch and Deutsche Bank Securities Inc. will act as joint book running managers for the offering. The public offering is being made by means of a prospectus supplement. Chemours has filed a shelf registration statement (including a prospectus) with the Securities and Exchange Commission (the "SEC") for the offering to which this communication relates. You may review these documents for free by visiting EDGAR on the SEC's website, at www.sec.gov. Alternatively, these documents may be obtained from Citigroup Global Markets Inc. by calling toll-free at 1-800-831-9146; from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by calling (866) 803-9204; from Barclays Capital Inc., Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, email: Barclaysprospectus@broadridge.com, or by calling toll free: 1-888-603-5847; from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, New York 10010, telephone: 1-800-221-1037, or email: newyork.prospectus@credit-suisse.com; from HSBC Securities (USA) Inc. by calling toll-free at 866-811-8049; from RBC Capital Markets, LLC, 200 Vesey Street, 8th Floor New York, New York 10281, Attention: Leveraged Capital Markets; or by telephone at 1-877-280-1299; from BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or e-mail dg.prospectus_requests@baml.com; or from Deutsche Bank Securities Inc., 60 Wall Street, New York, New York 10005, telephone: 1-800-503-4611, or email: prospectus.CPDG@db.com. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Such an offer can only be made by delivery of a prospectus and prospectus supplement, if applicable, that have been filed with the SEC. This press release is not an offer to purchase or the solicitation of an offer to sell any of the existing 2023 notes. The Tender Offers referenced herein are being made only by and pursuant to the terms of the applicable Offer to Purchase and Consent Solicitation Statement, with respect to the existing 2023 dollar notes, and a related letter of transmittal and consent. The statements in this press release with respect to the redemptions of the existing 2023 notes do not constitute notices of redemption under the indentures governing the existing 2023 notes. Any such notices have or will be sent to holders of existing 2023 notes only in accordance with the provisions of such indentures. About The Chemours Company Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com. Forward-Looking Statements CONTACT MEDIA INVESTORS View original content:http://www.prnewswire.com/news-releases/chemours-announces-commencement-of-public-offering-of-senior-notes-300651714.html SOURCE The Chemours Company | ||
Company Codes: NYSE:CC |
© 2018 PR Newswire. All Rights Reserved.